Who will benefit from prescription drug price regulation changes? – InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Senior Health
Topics
    • Life Insurance News
    • Annuity News
    • Health/Employee Benefits
    • Property and Casualty
    • Advisor News
    • Washington Wire
    • Regulation News
    • Sponsored Articles
    • Monthly Focus
  • INN Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
Sign in or register to be an INNsider.
  • Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
  • Insider Pro
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Newsletters

Get Social

  • Facebook
  • Twitter
  • LinkedIn
Monthly Focus
Senior Health RSS Get our newsletter
Order Prints
October 1, 2022 Senior Health No comments
Share
Share
Tweet
Email

Who will benefit from prescription drug price regulation changes?

Who will benefit from changes in prescription drug regulations.
Prescription Medication Medicine Pill Tablets
By Susan Rupe

The Inflation Reduction Act, passed Aug. 12,  includes a sweeping overhaul of prescription drug pricing regulation. Who will benefit from this and who will not? A panel of consultants from Manatt Health looked at the implications of new federal drug price regulation across the health care system during a recent webinar.

The act has three main provisions that change prescription drug pricing.

  1. Price negotiation. Allows the government to regulate the price of certain drugs under Medicare for the first time under the Drug Price Negotiation Program, through which the government must establish a “maximum fair price (MFP)” for certain drugs.
  2. Inflation penalties. Requires pharmaceutical manufacturers to pay rebates on drugs covered under Medicare Part B and Part D if they increase prices faster than the rate of inflation.
  3. Medicare Part D. Overhauls the Medicare Part D benefit by creating an annual $2,000 out of pocket cap on Part D prescription drug spending.

Five key sectors of the health care system will be impacted by this new regulation. They include drug manufacturers, payers, providers, state Medicaid agencies and patients.

Related stories

  • AHIP focusing on health care affordability and accessibility in 2023
  • CEO survey: Recession is the biggest worry in 2023

Drug manufacturers

The drug negotiation program will reduce manufacturers’ Medicare revenue form existing brand drugs, said Adam Finkelstein, partner with Manatt Health. Manufacturers of drugs that are not subject to negotiation may also see lower revenue as they compete against complementary products that have a negotiated price. Inflation caps will limit price increases and expected revenue from brand drugs.

One of the biggest advantages to these regulations, Finkelstein said, is that Part D redesign will lower patient out-of-pocket costs. This will have an especially big impact on insulin, specialty drugs and vaccines.

But on the minus side, he said, manufacturers will see lower overall revenue. Manufacturers will have less incentive to research new indications for existing drugs, especially orphan drugs. In addition, Part D manufacturer rebates may be more costly for some beneficiaries than the current Coverage Gap Discount Program.

Medicare Part D plan sponsors

Drug price regulations establish a $2,000 annual beneficiary cost-sharing cap effective in 2025, as well as eliminating catastrophic beneficiary cost-sharing for 2023 and 2024, said Michael Kolber, partner with Manatt Health. Part D beneficiary premiums are capped for 2024 through 2029.

Kolber said that overall premiums – at least initially – will increase due to cost-sharing limits, while beneficiary premium increases will be limited. However, plans will be at higher risk for high-cost drugs and plans may lose rebate revenue from formerly high-priced drugs.

Medicare Advantage plans also will be impacted by price negotiation and inflation rebates on Part B drugs, Kolber said. Negotiated drug prices and inflationary rebates may reduce Medicare Advantage plans’ costs for Part B drugs. However, he said, overall federal payment to Medicare Advantage plans may decline as Part B drug spending moderates, which impacts the fee-for-service benchmark.

Some spillover into employer-sponsored plans also may be seen as a result of negotiated drug prices, Kolber said. Sponsors of employer/union group Medicare plans may see lower costs, he said, and supplementary benefits in group Medicare plans will count toward the new $2,000 patient Part D out-of-pocket maximum, making it more attractive for employers to supplement benefits. Some employers fear that drug costs will shift from Medicare to employers. But the high visibility of the lower Medicare prices could create additional leverage for commercial payers to negotiate lower net prices.

Susan Rupe is managing editor for InsuranceNewsNet. She formerly served as communications director for an insurance agents' association and was an award-winning newspaper reporter and editor. Contact her at [email protected]. Follow her on Twitter @INNsusan.

© Entire contents copyright 2022 by InsuranceNewsNet.com Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.

Older

In the right room — With Joyce Yoo

Newer

Unbundled, untied & un-mutualized: The road to fiduciary

Advisor News

  • For some, nothing to fear from taking RMDs, professor says
  • Half of investors plan to work after retirement
  • Cetera to acquire Securian’s retail wealth business
  • Study: Education level should drive decisions on Social Security, annuities
  • Former California energy company exec given 5 years in prison for $15M investment fraud
More Advisor News

Annuity News

  • Investors scrambling to lock in rates propel annuity sales to record highs
  • North American and Annexus launch new fixed index annuity
  • Producers stew as insurers slow to process life and annuity applications
  • Substitute teacher wins massive lottery drawing in North Carolina. ‘Too good to be true’
  • Brad Rhodes: An annuity product many have never heard of
More Annuity News

Health/Employee Benefits News

  • Nearly half of all gig workers have no access to health insurance
  • California offers health insurance for $10 a month. The deadline is days away
  • Amazon announces service to deliver medications to your door. Here’s how it works
  • COVID-19Another COVID ‘new normal’: more Californians dying at home
  • Seven sentenced in conspiracy to defraud federal health insurance programs
More Health/Employee Benefits News

Life Insurance News

  • Cetera to acquire Securian’s retail wealth business
  • What does Curtis 'Cousin Eddie' Smith know in Murdaugh case?
  • Alex Murdaugh's murder trial starts with cellphones, bullets
  • Prosecutors, defense argue guns, bad acts in Murdaugh trial
  • Lincoln Financial Group offers new, fully automated life product, WealthAccelerate
Sponsor
More Life Insurance News
The time is 05:38:58am test

- Presented By -

Top Read Stories

  • A Louisiana employer's health perks helped their workers lose weight. Here’s how.
  • US debt ceiling limit reached; Social Security, Medicare targeted
  • Former CEO of Texas beverage company sentenced to 10 years in prison for fraud
  • LETTER: FEMA flood insurance is all but worthless
  • Will ChatGPT, artificial intelligence replace financial professionals any time soon?
More Top Read Stories >

FEATURED OFFERS

Grow life insurance sales in 2023 with middle-market clients

Tap a new source for sales and referrals with Allianz Life Insurance Company of North America.

Don't Miss ICMG 2023

When the success of your business depends on making the right connections, ICMG is the place to be.

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty
  • Advisor News
  • Washington Wire
  • Regulation News
  • Sponsored Articles
  • Monthly Focus

Top Sections

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits News
  • Property and Casualty News
  • AdvisorNews
  • Washington Wire
  • Insurance Webinars

Our Company

  • About
  • Editorial Staff
  • Magazine
  • Write for INN
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2023 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • AdvisorNews

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.